Production and Semi-Automated Processing of <sup>89</sup>Zr Using a Commercially Available TRASIS MiniAiO Module

Production and Semi-Automated Processing of <sup>89</sup>Zr Using a Commercially Available TRASIS MiniAiO Module

The increased interest in <sup>89</sup>Zr-labelled immunoPET imaging probes for use in preclinical and clinical studies has led to a rising demand for the isotope. The highly penetrating 511 and 909 keV photons emitted by <sup>89</sup>Zr deliver an undesirably high radiation...

Full description

Bibliographic Details
Main Authors:	Vijay Gaja, Jacqueline Cawthray, Clarence R. Geyer, Humphrey Fonge
Format:	Article
Language:	English
Published:	MDPI AG 2020-06-01
Series:	Molecules
Subjects:	Zirconium-89 automation radiolabelling
Online Access:	https://www.mdpi.com/1420-3049/25/11/2626

Similar Items

A Semi Rigid Novel Hydroxamate AMPED-Based Ligand for <sup>89</sup>Zr PET Imaging
by: Lisa Russelli, et al.
Published: (2021-09-01)

From Bench to Bedside: Patient-Oriented Radiopharmaceutical Development in Nuclear Medicine Based on the Example of [<sup>89</sup>Zr]Zr-PSMA-DFO
by: Klaus Schomäcker, et al.
Published: (2023-12-01)

In Vitro and In Vivo Characterization of <sup>89</sup>Zirconium-Labeled Lintuzumab Molecule
by: Kevin J. H. Allen, et al.
Published: (2022-10-01)

HER3 PET Imaging: <sup>68</sup>Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to <sup>89</sup>Zr-Labeled Antibody and Antibody-Fragment-Based Tracers
by: Sara S. Rinne, et al.
Published: (2021-09-01)

<sup>89</sup>Zr-Labeled AR20.5: A MUC1-Targeting ImmunoPET Probe
by: Kimberly Fung, et al.
Published: (2020-05-01)

A generic 89Zr labeling method to quantify the in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography
by: Li N, et al.
Published: (2017-04-01)

<sup>89</sup>Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo
by: Elahe Alizadeh, et al.
Published: (2021-02-01)

89Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigations
by: Maryke Kahts, et al.
Published: (2023-11-01)

Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET
by: Jessica E. Wijngaarden, et al.
Published: (2024-02-01)

Current Perspectives on <sup>89</sup>Zr-PET Imaging
by: Joon-Kee Yoon, et al.
Published: (2020-06-01)

Toward Optimized <sup>89</sup>Zr-Immuno-PET: Side-by-Side Comparison of [<sup>89</sup>Zr]Zr-DFO-, [<sup>89</sup>Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [<sup>89</sup>Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
by: Helen Damerow, et al.
Published: (2022-10-01)

Recent Advances in Zirconium-89 Chelator Development
by: Nikunj B. Bhatt, et al.
Published: (2018-03-01)

In Vivo PET Imaging of Monocytes Labeled with [<sup>89</sup>Zr]Zr-PLGA-NH<sub>2</sub> Nanoparticles in Tumor and <i>Staphylococcus aureus</i> Infection Models
by: Massis Krekorian, et al.
Published: (2021-10-01)

Preclinical Pharmacokinetics and Dosimetry of an 89Zr Labelled Anti-PDL1 in an Orthotopic Lung Cancer Murine Model
by: Anis Krache, et al.
Published: (2022-01-01)

[<sup>89</sup>Zr]-Atezolizumab-PET Imaging Reveals Longitudinal Alterations in PDL1 during Therapy in TNBC Preclinical Models
by: Adriana V. F. Massicano, et al.
Published: (2023-05-01)

Detection limit of 89Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRI
by: Laura M. Lechermann, et al.
Published: (2020-07-01)

The Race for Hydroxamate-Based Zirconium-89 Chelators
by: Irene V. J. Feiner, et al.
Published: (2021-09-01)

In vivo amyloid-β imaging in the APPPS1-21 transgenic mouse model with a 89Zr- labeled monoclonal antibody.
by: Ann-Marie eWaldron, et al.
Published: (2016-03-01)

Preclinical PET and MR Evaluation of <sup>89</sup>Zr- and <sup>68</sup>Ga-Labeled Nanodiamonds in Mice over Different Time Scales
by: Gordon Winter, et al.
Published: (2022-12-01)

<sup>89</sup>Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs
by: Iris H. C. Miedema, et al.
Published: (2023-11-01)

Biodistribution of Mesenchymal Stromal Cells Labeled with [<sup>89</sup>Zr]Zr-Oxine in Local Radiation Injuries in Laboratory Animals
by: Tatiana A. Astrelina, et al.
Published: (2023-10-01)

Quantitative Biodistribution and Pharmacokinetics Study of GMP-Grade Exosomes Labeled with <sup>89</sup>Zr Radioisotope in Mice and Rats
by: Hojun Choi, et al.
Published: (2022-05-01)

89Zr-labeled ImmunoPET targeting the cancer stem cell antigen CD133 using fully-human antibody constructs
by: Kevin Wyszatko, et al.
Published: (2024-03-01)

Synthesis of Zr-89-Labeled Folic Acid-Conjugated Silica (SiO<sub>2</sub>) Microwire as a Tumor Diagnostics Carrier for Positron Emission Tomography
by: Gun Gyun Kim, et al.
Published: (2021-06-01)

Comparative Study with 89Y-foil and 89Y-pressed Targets for the Production of 89Zr †
by: Aiman H. Alnahwi, et al.
Published: (2018-09-01)

Immuno-PET Imaging of Atherosclerotic Plaques with [<sup>89</sup>Zr]Zr-Anti-CD40 mAb—Proof of Concept
by: Kikkie Poels, et al.
Published: (2022-03-01)

Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of <sup>89</sup>Zr Immune-PET Tracers
by: Ryota Imura, et al.
Published: (2021-08-01)

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body <sup>18</sup>F-Fluorodeoxyglucose and <sup>89</sup>Zr-Rituximab PET Scans
by: Bart M. de Vries, et al.
Published: (2022-02-01)

Radiolabelling of Polyclonally Expanded Human Regulatory T Cells (Treg) with <sup>89</sup>Zr-oxine for Medium-Term <i>In Vivo</i> Cell Tracking
by: Jacinta Jacob, et al.
Published: (2023-02-01)

Comparative in vivo biodistribution of cells labelled with [89Zr]Zr-(oxinate)4 or [89Zr]Zr-DFO-NCS using PET
by: Ida Friberger, et al.
Published: (2023-08-01)

[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis
by: Florian Rosar, et al.
Published: (2024-02-01)

PET Imaging of Acidic Tumor Environment With 89Zr-labeled pHLIP Probes
by: David Bauer, et al.
Published: (2022-05-01)

Evaluation of Chelator-to-Antibody Ratio on Development of <sup>89</sup>Zr-iPET Tracer for Imaging of PD-L1 Expression on Tumor
by: Shih-Chuan Tsai, et al.
Published: (2023-12-01)

Histologically Confirmed Testicular Metastasis Revealed by [<sup>89</sup>Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging
by: Florian Rosar, et al.
Published: (2023-04-01)

Side-by-Side Comparison of Five Chelators for <sup>89</sup>Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability
by: Helen Damerow, et al.
Published: (2021-12-01)

Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89
by: Chuangyan Zhai, et al.
Published: (2019-03-01)

Isotopic Radiolabeling of the Antiretroviral Drug [<sup>18</sup>F]Dolutegravir for Pharmacokinetic PET Imaging
by: Marion Tisseraud, et al.
Published: (2022-05-01)

Immuno-positron emission tomography with zirconium-89-labeled monoclonal antibodies in oncology
by: Yvonne W.S. Jauw, et al.
Published: (2016-05-01)

Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example
by: Marc C. Huisman, et al.
Published: (2021-08-01)

Radiosynthesis of [<sup>18</sup>F]-Labelled Pro-Nucleotides (ProTides)
by: Alessandra Cavaliere, et al.
Published: (2020-02-01)